XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 44.97

Change

-0.23 (-0.51)%

Market Cap

CAD 0.60B

Volume

3.80K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.16 (-0.11%)

CAD 22.27B
ZSP:CA BMO S&P 500

-0.16 (-0.17%)

CAD 19.82B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.30 (-0.48%)

CAD 11.85B
VUN:CA Vanguard US Total Market

-0.23 (-0.20%)

CAD 11.53B
XUS:CA iShares Core S&P 500 Index ETF

-0.04 (-0.07%)

CAD 8.94B
HXS:CA Global X S&P 500 Corporate Cla..

-0.25 (-0.29%)

CAD 4.81B
VSP:CA Vanguard S&P 500 CAD hedged

-0.41 (-0.42%)

CAD 4.32B
QUU:CA Mackenzie US Large Cap Equity ..

-1.09 (-0.44%)

CAD 3.65B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.65 (-1.22%)

CAD 3.55B
XUU:CA iShares Core S&P US Total Mark..

-0.13 (-0.21%)

CAD 3.54B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.13% 10% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.13% 10% F 31% F
Trailing 12 Months  
Capital Gain 23.58% 76% C+ 80% B-
Dividend Return 1.02% 28% F 12% F
Total Return 24.60% 76% C+ 77% C+
Trailing 5 Years  
Capital Gain 107.81% 86% B+ 86% B+
Dividend Return 7.21% 19% F 12% F
Total Return 115.02% 79% B- 83% B
Average Annual (5 Year Horizon)  
Capital Gain 15.43% 76% C+ 79% B-
Dividend Return 16.32% 75% C 77% C+
Total Return 0.88% 30% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.76% 37% F 54% F
Risk Adjusted Return 103.53% 61% D- 94% A
Market Capitalization 0.60B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.